BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32048092)

  • 1. Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients.
    Jia M; Yu S; Cao L; Sun PL; Gao H
    Ann Surg Oncol; 2020 Aug; 27(8):3052-3063. PubMed ID: 32048092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung.
    Yotsukura M; Asamura H; Motoi N; Kashima J; Yoshida Y; Nakagawa K; Shiraishi K; Kohno T; Yatabe Y; Watanabe SI
    J Thorac Oncol; 2021 Aug; 16(8):1312-1320. PubMed ID: 33915249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of
    Shen L; Lin J; Wang B; Xu H; Zhao K; Zhang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Sep; 39(9):1107-1112. PubMed ID: 31640952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
    Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
    Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma.
    Yagi T; Yamazaki M; Ohashi R; Ogawa R; Ishikawa H; Yoshimura N; Tsuchida M; Ajioka Y; Aoyama H
    Jpn J Radiol; 2018 Feb; 36(2):113-121. PubMed ID: 29273964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
    Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
    Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT features and quantitative analysis of subsolid nodule lung adenocarcinoma for pathological classification prediction.
    Li X; Zhang W; Yu Y; Zhang G; Zhou L; Wu Z; Liu B
    BMC Cancer; 2020 Jan; 20(1):60. PubMed ID: 31992239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
    Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
    Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
    Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
    J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for pre- and minimally invasive lung adenocarcinoma.
    Zhang Y; Ma X; Shen X; Wang S; Li Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):456-464. PubMed ID: 33485660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating between bronchiolar adenoma, adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung with CT.
    Cao L; Wang Z; Gong T; Wang J; Liu J; Jin L; Yuan Q
    Diagn Interv Imaging; 2020 Dec; 101(12):831-837. PubMed ID: 32482582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules.
    She Y; Zhang L; Zhu H; Dai C; Xie D; Xie H; Zhang W; Zhao L; Zou L; Fei K; Sun X; Chen C
    Eur Radiol; 2018 Dec; 28(12):5121-5128. PubMed ID: 29869172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.
    Liu Y; Sun H; Zhou F; Su C; Gao G; Ren S; Zhou C; Zhang Z; Shi J
    Lung Cancer; 2017 Jun; 108():192-197. PubMed ID: 28625634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.
    Naito M; Aokage K; Saruwatari K; Hisakane K; Miyoshi T; Hishida T; Yoshida J; Masato S; Kojima M; Kuwata T; Fujii S; Ochiai A; Sato Y; Tsuboi M; Ishii G
    Lung Cancer; 2016 Oct; 100():53-62. PubMed ID: 27597281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography.
    Xiang W; Xing Y; Jiang S; Chen G; Mao H; Labh K; Jia X; Sun X
    Cancer Imaging; 2014 Nov; 14(1):33. PubMed ID: 25608623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma.
    Cho HH; Lee G; Lee HY; Park H
    Eur Radiol; 2020 May; 30(5):2984-2994. PubMed ID: 31965255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can computed tomography differentiate adenocarcinoma in situ from minimally invasive adenocarcinoma?
    Yoshida M; Yuasa M; Ogawa H; Miyamoto N; Kawakami Y; Kondo K; Tangoku A
    Thorac Cancer; 2021 Apr; 12(7):1023-1032. PubMed ID: 33599059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histogram analysis combined with morphological characteristics to discriminate adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma appearing as pure ground-glass nodule.
    Zhang T; Pu XH; Yuan M; Zhong Y; Li H; Wu JF; Yu TF
    Eur J Radiol; 2019 Apr; 113():238-244. PubMed ID: 30927953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.